Alzheimer’s Disease and Inflammaging

Abstract

Alzheimer’s disease is one of the most common age-related neurodegenerative disorders. The main theory of Alzheimer’s disease progress is the amyloid-β cascade hypothesis. However, the initial mechanisms of insoluble forms of amyloid-β formation and hyperphosphorylated tau protein in neurons remain unclear. One of the factors, which might play a key role in senile plaques and tau fibrils generation due to Alzheimer’s disease, is inflammaging, i.e., systemic chronic low-grade age-related inflammation. The activation of the proinflammatory cell phenotype is observed during aging, which might be one of the pivotal mechanisms for the development of chronic inflammatory diseases, e.g., atherosclerosis, metabolic syndrome, type 2 diabetes mellitus, and Alzheimer’s disease. This review discusses the role of the inflammatory processes in developing neurodegeneration, activated during physiological aging and due to various diseases such as atherosclerosis, obesity, type 2 diabetes mellitus, and depressive disorders.

Leveraging Electronic Medical Records and Knowledge Networks to Predict Disease Onset and Gain Biological Insight Into Alzheimer’s Disease

“…We also identify relative importance of features years in advance, such as allergic rhinitis and atrial fibrillation as early predictors, osteoporosis and dizziness as non-neurological predictors, and cognitive impairment and vitamin D deficiency as late predictors of AD. These findings potentially support hypotheses suggesting AD can be associated with general aging or frailty, which might present in non-neurologic body systems either prior to or concurrent with AD [34][35][36][37][38] . Nevertheless, while these models can identify hypotheses of predictive features, EHR data can still capture clinical biases or misdiagnoses, and further studies can investigate the influence of behavioral bias vs biological relevance.…”

Intracellular Molecular Targets and Signaling Pathways Involved in Antioxidative and Neuroprotective Effects of Cannabinoids in Neurodegenerative Conditions

“…As previously mentioned, the most prominent activators of immune response are aggregated protein forms and other danger-associated molecular patterns originating from damaged and dying cells. These molecular motifs activate the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) transcription factor that initiates the production of inflammatory cytokines and chemokines that recruit microglial cells to the site of injury [ 157 , 168 ]. NF-κB also directs the expression of the superoxide anion-producing enzyme NADPH oxidase and the NO-producing enzyme iNOS.…”

Engineered mesenchymal stem cell-derived extracellular vesicles: A state-of-the-art multifunctional weapon against Alzheimer's disease

“…Typical pathological changes of AD are the accumulation of β-amyloid plaques and hyperphosphorylation of Tau in neurofibrillary tangles [1,2]. Such pathological protein deposition damages the cerebral cortex and hippocampal neurons, while the release of inflammatory mediators by microglia and astrocytes during the brain immune response may in turn exacerbate the chronic neuroinflammation of AD patients [3,4].…”